The quest for a cure for cancer is a never-ending one but fortunately, the extent of research going on around the world on a war footing is yielding results. A promising new study at Stanford Medical Institute has just finished testing a new vaccine that kills almost 97% of cancerous tumors in mice. But hold that yawn!! This isn’t just another study because this one is all set to go into human clinical trials where the institute is in the very process of accepting patients with non-Hodgkin’s lymphoma to be part of the unique new phase of trials.
1Human patients to be accepted for trial
Advertisement
Even though experts feel that it is a long road to the point where the drug may be administered to cancer patients, the fact remains is that 35 patients will be taken for trial and testing and if that succeeds, it would be a huge boost in the war against cancer. The biggest advantage of the vaccine is that it is chemotherapy free.
Image Source: hdnux.com
2Vaccine uses the immune system to fight cancer
Advertisement
The new cancer vaccine looks very promising feel researchers and now Stanford will test the same on 35 people with Lymphoma a dreaded form of cancer. The test will be carried out by the end of this year.
Image Source: dailymail.co.uk
3The new vaccine is free from chemotherapy
Advertisement
SF gate a news outlet in San Francisco reported that the new vaccine is free from chemo and involves the body’s immune system to fight off cancer and heal itself. Based on immunotherapy which is a fairly recent treatment, it is quite successful in other cancers.
Image Source: cosmos.net
4Immunotherapy to attack and kill cancer cells
Advertisement
The new cancer vaccine that was tested on mice in Stanford institute engaged the new medical area of immunotherapy that seeks to stimulate the body’s immunity to attack and kill cancer cells and tumors. The research was led by Doctor Ronald Levy and Doctor Idit Sagit Barfi.
Image Source: hdnux.com